| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 136, 17-21, Copyright © 1990 by American Society for Investigative Pathology
REGULAR ARTICLES |
AS Jack, AW Boylston, S Carrel and I Grigor
Pathology Department, Leeds University, England.
Monoclonal antibodies that recognize the proteins specified by two families of T-cell antigen receptor variable region genes were assessed as clonal markers in cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). About 3% to 5% of tumors were expected to react with each antibody. However, 10 of 16 cases studied reacted with MAbs specific for the V beta 8 gene family. All the positive cases were examples of the plaque or tumor stages of CTCL. None of the cases of eczematoid or premycotic CTCL showed uniform reactivity with these antibodies. Unexpected use of one particular V gene family raises the possibility that CTCL derives from a distinct subpopulation of antigen- or virus-selected T cells.
This article has been cited by other articles:
![]() |
S. Ingen-Housz-Oro, A. Bussel, B. Flageul, L. Michel, L. Dubertret, P. Kourilsky, G. Gachelin, H. Bachelez, and P. Musette A prospective study on the evolution of the T-cell repertoire in patients with Sezary syndrome treated by extracorporeal photopheresis Blood, August 28, 2002; 100(6): 2168 - 2174. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Jackow, J. C. Cather, V. Hearne, A. T. Asano, J. M. Musser, and M. Duvic Association of Erythrodermic Cutaneous T-Cell Lymphoma, Superantigen-Positive Staphylococcus aureus, and Oligoclonal T-Cell Receptor Vbeta Gene Expansion Blood, January 1, 1997; 89(1): 32 - 40. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |